Literature DB >> 18028485

High D-dimer level is associated with increased 15-d and 3 months mortality through a more central localization of pulmonary emboli and serious comorbidity.

F A Klok1, R Karami Djurabi, M Nijkeuter, H C J Eikenboom, F W G Leebeek, M H H Kramer, K Kaasjager, P W Kamphuisen, H R Büller, M V Huisman.   

Abstract

High D-dimer levels are predictors of death in patients with pulmonary embolism (PE), as are more proximally located, larger emboli. The direct link between these three has not yet been described. A cohort of 674 consecutive patients with confirmed PE was studied. Patients were followed up for 3 months. D-dimer levels were measured only in patients with an unlikely clinical probability (n = 262). The odds ratio (OR) for death of all variables was calculated. Multivariate analysis was performed to identify independent risk factors for mortality. The best predictive D-dimer cut-off point for mortality was a concentration >3000 ng/ml FEU (OR 7.29). High D-dimer levels were correlated with active malignancy and age over 65 years, both being indicators of 3-month mortality. High D-dimer levels were also correlated with centrally located pulmonary emboli and 15-d mortality. The combination of high D-dimer levels and central emboli increased early mortality risk by 2.2. High D-dimer levels in patients with an unlikely clinical probability were associated with fatal outcome after PE. Centrally located pulmonary emboli were associated with higher D-dimer levels and worse 15-d mortality. Active malignancy, being an inpatient at time of diagnosis and age over 65 years were associated with higher D-dimer levels and worse 3-month survival.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18028485     DOI: 10.1111/j.1365-2141.2007.06888.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  8 in total

1.  Relationship between polycythemia and in-hospital mortality in chronic obstructive pulmonary disease patients with low-risk pulmonary embolism.

Authors:  Lu Guo; Aamer Rasheed Chughtai; Hongli Jiang; Lingyun Gao; Yan Yang; Yang Yang; Yuejian Liu; Zhenliang Xie; Weimin Li
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

2.  Treatment of Submassive Pulmonary Embolism: Knowing When to be Aggressive and When to be Conservative.

Authors:  David L Ain; Michael R Jaff
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-06

Review 3.  D-dimer for risk stratification in patients with acute pulmonary embolism.

Authors:  Cecilia Becattini; Alessandra Lignani; Luca Masotti; Maria Beatrice Forte; Giancarlo Agnelli
Journal:  J Thromb Thrombolysis       Date:  2012-01       Impact factor: 2.300

Review 4.  Novel biomarkers for risk stratification and identification of life-threatening cardiovascular disease: troponin and beyond.

Authors:  Louai Razzouk; Mario Fusaro; Ricardo Esquitin
Journal:  Curr Cardiol Rev       Date:  2012-05

5.  Lower prevalence of subsegmental pulmonary embolism after application of the YEARS diagnostic algorithm.

Authors:  Liselotte M van der Pol; Ingrid M Bistervels; Thijs E van Mens; Tom van der Hulle; Ludo F M Beenen; Paul L den Exter; Lucia J M Kroft; Albert T A Mairuhu; Saskia Middeldorp; Jaap M van Werkhoven; Marije Ten Wolde; Menno V Huisman; Frederikus A Klok
Journal:  Br J Haematol       Date:  2018-09-10       Impact factor: 6.998

Review 6.  Diagnostic Management of Acute Pulmonary Embolism in COVID-19 and Other Special Patient Populations.

Authors:  Emily S L Martens; Menno V Huisman; Frederikus A Klok
Journal:  Diagnostics (Basel)       Date:  2022-05-30

7.  Central Versus Peripheral Pulmonary Embolism: Analysis of the Impact on the Physiological Parameters and Long-term Survival.

Authors:  José Luis Alonso Martinez; Francisco Javier Anniccherico Sánchez; Miren Aranzazu Urbieta Echezarreta; Ione Villar García; Jorge Rojo Álvaro
Journal:  N Am J Med Sci       Date:  2016-03

8.  The predictive value of PaO2/FIO2 and additional parameters for in-hospital mortality in patients with acute pulmonary embolism: an 8-year prospective observational single-center cohort study.

Authors:  Yan Wang; He Yang; Lisong Qiao; Zheng Tan; Jin Jin; Jingjing Yang; Li Zhang; Bao Min Fang; Xiaomao Xu
Journal:  BMC Pulm Med       Date:  2019-12-10       Impact factor: 3.317

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.